Shivyaa
Natural health product licensed in Canada
- Licence holder
- Devang Holdings Private Limited
- NPN or DIN-HM
- 80067971
- Status
- Active licence
- Licence date
- 23 March 2016
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Substance interdite
Contains the plant Garcinia cambogia (Garcinia gummi-gutta). In France, importing and placing food supplements containing it on the market are suspended until 17 April 2027 (arrêté du 16 avril 2026).
arrêté du 16 avril 2026 (JORFTEXT000053907152). French orders suspending food supplements containing a plant (Official Journal), checked against the text, retrieved 23 October 2026.
Order published in the French Official Journal, read on Légifrance.
- Conditions légales
Nigella sativa L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les enfants, adolescents, femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Cassia fistula L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes et une mention déconseillant l'usage prolongé.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Trigonella foenum-graecum L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Nigella sativa Source : Semence(s) | 0.23 g | Not calculated |
| Pterocarpus marsupium Source : Bois (de coeur) de Campêche | 0.3 g | Not calculated |
| Aegle marmelos Source : Feuille | 0.3 g | Not calculated |
| Cassia fistula Source : Fruit | 0.3 g | Not calculated |
| Momordica charantia Source : Fruit | 0.3 g | Not calculated |
| Azadirachta indica Source : Feuille | 0.3 g | Not calculated |
| Tinospora cordifolia Source : Tige | 0.3 g | Not calculated |
| Azadirachta indica Source : Fruit | 0.3 g | Not calculated |
| Gymnema sylvestre Source : Racine | 0.3 g | Not calculated |
| Trigonella foenum-graecum Source : Graine(s) | 0.67 g | Not calculated |
| Syzygium cumini Source : Graine(s) | 0.4 g | Not calculated |
| Mangifera indica Source : Semence(s) | 0.4 g | Not calculated |
| Garcinia gummi-gutta Source : Graine(s) | 0.3 g | Not calculated |
| Terminalia arjuna Source : Écorce (tige) | 0.3 g | Not calculated |
| Capparis spinosa Source : Fruit | 0.3 g | Not calculated |
Non-medicinal ingredients
Not provided.
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Mesures | 3 Tous les jours |
Uses authorised in Canada
Used in Herbal Medicine as supportive therapy for the promotion of healthy glucose levels.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you have diabetes. If you experience symptoms of hypoglycaemia including feeling of anxiety, dizziness, tremor, sweating, nausea or headache, discontinue use and consult a health care practitioner.
Source
Official Health Canada record, licence 80067971
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.